News

June 17, 2011 — Endologix, Inc. announced it received U.S. Food and Drug Administration (FDA) approval for AFX Endovascular AAA System for the treatment of abdominal aortic aneurysms (AAA). The...
May 24, 2011 — Aptus Endosystems Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced CE mark approval for the Aptus EndoStapling System....
Aortic dissection is rare, but when it occurs, a patient’s prognosis can be poor, even with timely medical diagnosis and treatment. It is the most frequently diagnosed lethal condition of the aorta....

March 14, 2011 – A vascular graft for hemodialysis access has received the CE mark. The Gore Propaten vascular graft, from W.L. Gore and Associates, utilizes a covalent bonding technology to...

February 21, 2011 – The U.S. Food and Drug Administration has approved an endoprosthesis device for use on a lower profile delivery system. The Gore Viabahn Endoprosthesis with Heparin Bioactive...

January 24, 2011 – A new device for treating peripheral artery disease (PAD) is now available in Europe. W.L. Gore and Associates announced the availability of its Viabahn Endoprosthesis on a...

December 29, 2010 – The U.S. Food and Drug Administration (FDA) has approved a stent graft system for treating abdominal aortic aneurysms (AAA). The Endurant AAA Stent Graft System, from Medtronic...

November 24, 2010 - Rotational computed tomography angiography (CTA), a new noninvasive imaging modality, has the ability to display angiography in 3-D formats. This allows for considerable...

November 22, 2010 - An implantable medical device used in the minimally invasive treatment of abdominal aortic aneurysms delivered strong results through one year of patient follow-up in a U.S....

November 17, 2010 – A lunch symposium detailing the evidence for simulation in medical training and other fields will be sponsored by W.L. Gore and Associates at the VEITHsymposium. The EVEResT (...

November 8, 2010 – A new aortic extension has been implanted in a clinical setting for the first time. The Ventana fenestrated stent graft, by Endologix, was implanted at Auckland City Hospital in...

September 27, 2010 – A post-market study investigating a new treatment for peripheral artery disease of the superficial femoral artery (SFA) has completed enrollment.

The VIPER study, which...

September 17, 2010 - Clinical uses will soon begin for the C3 Delivery System for the Gore Excluder Device as a minimally invasive treatment for patients suffering from an abdominal aortic...

The first patient has been enrolled in the Medtronic Dissection Trial, which evaluates the clinical performance of the Valiant Thoracic Stent Graft with the Captivia Delivery System for the...

August 11, 2010 – New sizes of the SoloPath TransFemoral Endovascular Access Catheter were recently cleared by the U.S. Food and Drug Administration (FDA). The new sizes provide the potential to...

July 15, 2010 -- W. L. Gore and Associates recently announced that it has received the European CE mark approval for the 25 cm Gore Viabahn Endoprosthesis with Propaten Bioactive Surface. The Gore...

July 6, 2010 – Maquet Cardiovascular LLC recently announced it will become the exclusive U.S. distributor of the InterGard family of vascular grafts. This will go into effect on Oct. 1, 2010, when...

June 15, 2010 – Patients with smaller abdominal aortic aneurysms (AAAs) (less than 5.5 cm) have no significant differences in clinical outcomes after endovascular repair (EVAR) than those with...

June 14, 2010 – A new Internet, cloud-based, 3-D advanced visualization and decision support system aids physicians in endovascular case planning, The software was released this week at the...

June 8, 2010 – A 45 mm diameter stent graft to treat thoracic aortic aneurysms (TAA) has been cleared by the U.S. Food and Drug Administration (FDA). W. L. Gore & Associates said its new,...